NewGen Therapeutics, Inc. logo

NewGen Therapeutics, Inc.

NewGen Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to treat cancer patients.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.newgenther.com
Disease Focus
STOCK CODENon Listed
Address
3475 Edison Way, Suite R, CA 94025
Menlo Park
United States
Email
Contact Number
+1 650-995-7508

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/newgen-therapeutics” connections=”true” suffix=””]

In Dec 2011, NewGen acquired three oncology programs (targeting pan-erbB, EGFR/Her-2, and PARP) from Kanion USA, Inc. and Kanion Pharmaceutical Co., Ltd. in undisclosed amount.